Carcinoma: all 6,718 studies
Page 7 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal CarcinomaNot yet recruitingNCT05996484Phase 2
- SIRT for Potentially Resectable HCCRecruitingNCT05994859Not applicable
- Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal CarcinomaRecruitingNCT05994170Not applicable
- Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCCNot yet recruitingNCT05993858Phase 2
- Lenvatinib, Sintilimab Plus SIRT for Unresectable HCCRecruitingNCT05992584Phase 2
- Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular InvasionRecruitingNCT05992220Phase 2
- Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort AnalysisRecruitingNCT05990959
- Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing ChemotherapyRecruitingNCT05990231Phase 2
- Multimodal Ultrasound and Hepatocellular Response to Local TreatmentsRecruitingNCT05987514Not applicable
- Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCCRecruitingNCT05985798Phase 3
- Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell CarcinomaRecruitingNCT05984342Phase 1
- A Non-interventional Study With Advanced Lung Squamous Cell CarcinomaRecruitingNCT05984017
- Anrotinib and Tirelizumab in First-line Treatment of RM-NPCRecruitingNCT05981157Phase 2
- A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT05981066Not applicable
- Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）RecruitingNCT05980403
- Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial CarcinomaNot yet recruitingNCT05979909Phase 1
- A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive CytologyRecruitingNCT05977998Phase 2
- A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT05976568Phase 2/3
- Hepatic Artery Infusion of Adebrelimab Combined With Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma With Failure of Systemic Therapy Combined With Interventional TherapyNot yet recruitingNCT05975463Phase 2
- Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular CarcinomaRecruitingNCT05971199Phase 2
- Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular CarcinomaRecruitingNCT05970666Phase 2
- Study of MT-302 in Adults With Advanced or Metastatic Epithelial TumorsRecruitingNCT05969041Phase 1
- A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.RecruitingNCT05967689Phase 2
- Predictors of Sorafenib Response in HCCNot yet recruitingNCT05967429
- Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT05965154Phase 2
- Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant TherapyRecruitingNCT05964595
- Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell CarcinomaRecruitingNCT05964101Phase 2
- RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)RecruitingNCT05963464
- A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid CarcinomaRecruitingNCT05962892
- Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor TherapyRecruitingNCT05962450Phase 2
- Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular CarcinomaRecruitingNCT05957640Phase 1
- Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular CarcinomaRecruitingNCT05954897Phase 2
- HRYZ-T101 Injection for HPV18 Positive Solid TumorRecruitingNCT05952947Phase 1
- OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older AdultsNot yet recruitingNCT05949424Phase 4
- Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCCRecruitingNCT05941338Phase 2
- Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive NephrectomyNot yet recruitingNCT05941169Not applicable
- A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal CarcinomaRecruitingNCT05940441
- Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal CarcinomaRecruitingNCT05937438Phase 1/2
- FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint InhibitionRecruitingNCT05937295Phase 1
- Establishment of a Tissue Registry for Hepatocellular Carcinoma SpecimensRecruitingNCT05935189
- National Network Genomic Medicine Lung Cancer, GermanyRecruitingNCT05934032
- Excisional Vacuum-Assisted Breast BiopsyRecruitingNCT05932758Not applicable
- Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of IndicatorsRecruitingNCT05932719
- Topical Ascorbic Acid for Treatment of Squamous Cell Skin CancerRecruitingNCT05932511Early Phase 1
- Patient Perspectives in Squamous Cell Carcinoma Clinical TrialsNot yet recruitingNCT05929547
- XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell CarcinomaNot yet recruitingNCT05927844Phase 1
- WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMARecruitingNCT05927220
- GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular CarcinomaRecruitingNCT05926726Not applicable
- Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT05924997Phase 1/2
- Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence FactorsRecruitingNCT05920863Phase 2
- A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT05919030Phase 3
- Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma VirusRecruitingNCT05918510
- Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCCRecruitingNCT05917431Phase 2
- A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial CarcinomaRecruitingNCT05917158Phase 2
- Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)RecruitingNCT05917106
- Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)RecruitingNCT05913427Phase 2
- Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05913414Phase 2
- Disitamab Vedotin Combined With Radiotherapy for Bladder PreservationNot yet recruitingNCT05912205Phase 2
- Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or AblationNot yet recruitingNCT05910970Phase 3
- Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and CisplatinRecruitingNCT05910177Phase 2
- Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular CarcinomaNot yet recruitingNCT05908916Phase 2
- Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVCRecruitingNCT05905315Phase 2
- Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular CarcinomaNot yet recruitingNCT05903456Phase 2
- 68Ga-NY104 PET/CT Imaging in Renal Cell CarcinomaRecruitingNCT05902377Phase 2
- Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.Not yet recruitingNCT05900583
- Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT05898256Phase 1/2
- Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)RecruitingNCT05897268Phase 2
- A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker AnalysesNot yet recruitingNCT05897138Phase 2
- Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruitingNCT05896787Phase 2
- Utidelone Treated for the Recurrent or Metastatic Urothelial CarcinomaRecruitingNCT05895864Phase 2
- Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After ChemoradiotherapyRecruitingNCT05892354Not applicable
- Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving HepatectomyNot yet recruitingNCT05887505Not applicable
- HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 TrialRecruitingNCT05886465Phase 2
- Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of SkinRecruitingNCT05886140Not applicable
- Molecular Study and Precision Medicine for Colorectal CancerNot yet recruitingNCT05883683
- TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven CriteriaNot yet recruitingNCT05883176Phase 2
- TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II StudyRecruitingNCT05882370Phase 2
- 68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal MassesRecruitingNCT05879510Phase 2
- 68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT05879471Phase 2
- The ImmunoXXL StudyRecruitingNCT05879328
- Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal CarcinomaRecruitingNCT05877872Phase 3
- M-TACE Treatment for Unresectable Hepatocellular CarcinomaEnrolling by invitationNCT05875558Not applicable
- uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With JelmytoRecruitingNCT05874921
- TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.RecruitingNCT05872880
- H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein ThrombosisNot yet recruitingNCT05872841Phase 2
- 18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular CarcinomaRecruitingNCT05871892Not applicable
- Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular CarcinomaRecruitingNCT05866783
- HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCCRecruitingNCT05866172Phase 3
- A Study of Oncobax®-AK in Patients With Advanced Solid TumorsRecruitingNCT05865730Phase 2
- Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal JunctionRecruitingNCT05865132Phase 2
- HAIC Combined With Durvalumab, Tremelimumab and Bevacizumab as Conversion Therapy for Potentially Resectable Hepatocellular CarcinomaRecruitingNCT05864755Phase 2
- Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II TrialRecruitingNCT05862168Phase 2
- Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT05861557Phase 2
- Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05860868Phase 3
- Navigating the Clinical Trial Process for Hepatocellular CarcinomaNot yet recruitingNCT05859945
- Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma PatientsRecruitingNCT05858385
- Cadonilimab in Combination With Ramucirumab for the Treatment of Advanced Hepatocellular Carcinoma That Has Failed at Systemic TherapyRecruitingNCT05856864Phase 1
- Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial CarcinomaRecruitingNCT05856643Early Phase 1
- Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPCRecruitingNCT05854849Phase 3
- The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPRRecruitingNCT05854823Not applicable